Magnecine logo

Investor Presentation

Magnecine — Full Investor Presentation

Patent portfolio, clinical data, and licensing opportunity

Download Presentation
Investor Presentation

How Does It Work

Scientists reviewing Magnecine compound research

Dual-Action Composition

Magnecine combines two well-established therapeutic agents into a single, synergistic formulation. The first component is a proven anti-inflammatory agent — or its derivatives and analogues — that directly targets the inflammatory cascade responsible for disc-related pain.

The second component is a magnesium salt with documented antioxidant, vasodilating, and antispasmodic properties. Together, these agents address the root cause of Painful Damaged Disc Syndrome at the cellular level rather than simply masking symptoms.

How Does It Work — Full Presentation

PowerPoint · Mechanism of action, clinical data & treatment protocol

Download

Studies Done on Colchicine — Final

PowerPoint · Clinical research & study findings

Download

KEY HIGHLIGHTS

Doctor reviewing Magnecine treatment with patient

Investor Presentation

Magnecine represents a first-in-class analgesic opportunity. With multiple granted patents and a treatment effectiveness exceeding 90%, this is a compelling investment or licensing prospect for pharmaceutical and medical device companies.

Scientist examining Magnecine compound samples

Share the Big News

Progressive Health Partners has secured US and international patents covering both the proprietary composition and its method of use. This patent portfolio is now available for sale or licensing to qualified partners.

3D medical stethoscope illustration

Patient Outcomes

Patients treated with Magnecine report lasting relief — in many cases eliminating the need for invasive spinal epidural injections and surgeries. After a series of treatments, pain most often does not return.

FAQ

Customers have questions, you have answers.

Frequently asked questions about Magnecine and the patent opportunity.

Magnecine brand logo

INVESTOR PRESENTATION

Ready to Learn More?

The Magnecine patent portfolio represents a rare opportunity to acquire or license a first-in-class, clinically validated treatment for one of the most prevalent and costly pain conditions worldwide. Download the presentation above or contact us directly to discuss next steps.

REQUEST PRESENTATION